AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Kawarada, Y Ganss, R Garbi, N Sacher, T Arnold, B Hammerling, GJ
Citation: Y. Kawarada et al., NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides, J IMMUNOL, 167(9), 2001, pp. 5247-5253

Authors: Verreck, FAW Fargeas, CA Hammerling, GJ
Citation: Faw. Verreck et al., Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM, EUR J IMMUN, 31(4), 2001, pp. 1029-1036

Authors: Garbi, N Tan, P Diehl, AD Chambers, BJ Ljunggren, HG Momburg, F Hammerling, GJ
Citation: N. Garbi et al., Impaired immune responses and altered peptide repertoire in tapasin-deficient mice, NAT IMMUNOL, 1(3), 2000, pp. 234-238

Authors: Koopmann, JO Albring, J Huter, E Bulbuc, N Spee, P Neefjes, J Hammerling, GJ Momburg, F
Citation: Jo. Koopmann et al., Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel, IMMUNITY, 13(1), 2000, pp. 117-127

Authors: Arndt, SO Vogt, AB Markovic-Plese, S Martin, R Moldenhauer, G Wolpl, A Sun, YS Schadendorf, D Hammerling, GJ Kropshofer, H
Citation: So. Arndt et al., Functional HLA-DM on the surface of B cells and immature dendritic cells, EMBO J, 19(6), 2000, pp. 1241-1251

Authors: Hammerling, GJ Unanue, ER
Citation: Gj. Hammerling et Er. Unanue, Antigen presentation in 1998 and at the 10th International Congress of Immunology, IMMUNOLOGIS, 7(1-2), 1999, pp. 19-23

Authors: Vogt, AB Arndt, SO Hammerling, GJ Kropshofer, H
Citation: Ab. Vogt et al., Quality control of MHC class II associated peptides by HLA-DM/H2-M, SEMIN IMMUN, 11(6), 1999, pp. 391-403

Authors: Khare, SD Lee, S Bull, MJ Hanson, J Luthra, HS Hammerling, GJ David, CS
Citation: Sd. Khare et al., Peptide binding alpha 1 alpha 2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice, HUMAN IMMUN, 60(2), 1999, pp. 116-126

Authors: Hammerling, GJ Vogt, AB Kropshofer, H
Citation: Gj. Hammerling et al., Antigen processing and presentation - towards the Millennium, IMMUNOL REV, 172, 1999, pp. 5-9

Authors: Kropshofer, H Hammerling, GJ Vogt, AB
Citation: H. Kropshofer et al., The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules, IMMUNOL REV, 172, 1999, pp. 267-278

Authors: Alferink, J Aigner, S Reibke, R Hammerling, GJ Arnold, B
Citation: J. Alferink et al., Peripheral T-cell tolerance: the contribution of permissive T-cell migration into parenchymal tissues of the neonate, IMMUNOL REV, 169, 1999, pp. 255-261

Authors: Ganss, R Limmer, A Sacher, T Arnold, B Hammerling, GJ
Citation: R. Ganss et al., Autoaggression and tumor rejection: it takes more than self-specific T-cell activation, IMMUNOL REV, 169, 1999, pp. 263-272

Authors: Lobigs, M Mullbacher, A Blanden, RV Hammerling, GJ Momburg, F
Citation: M. Lobigs et al., Antigen presentation in Syrian hamster cells: substrate selectivity of TAPcontrolled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules, IMMUNOGENET, 49(11-12), 1999, pp. 931-941

Authors: Raddrizzani, L Bono, E Vogt, AB Kropshofer, H Gallazzi, F Sturniolo, T Hammerling, GJ Sinigaglia, F Hammer, J
Citation: L. Raddrizzani et al., Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM, EUR J IMMUN, 29(2), 1999, pp. 660-668

Authors: Hammerling, GJ Manoury, B Watts, C Adorini, L Lanzavecchia, A
Citation: Gj. Hammerling et al., Peptide binding and editing: generation of TCR ligands, RES IMMUNOL, 149(9), 1998, pp. 863-865
Risultati: 1-15 |